Furthermore, when assessing the effects of eHSP70 in the context of COPD the presence of inhibitory acting HSP auto-antibodies, which have been reported in COPD patient’s sputum and serum [42], has to be taken into account. The gene discussed is HSP90B2P; the disease is chronic obstructive pulmonary disease.